Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Reaman

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Journal of Biopharmaceutical Statistics|February 7, 2023
Clinical trial considerations for pediatric cancer drug developmentFreda Cooner, Jingjing Ye, Gregory Reaman
Pediatric Blood & Cancer|February 27, 2013
Patient-perceived facilitators in the transition of care for young adult survivors of childhood cancerKarim Thomas Sadak, Amanda Dinofia, Gregory Reaman
Pediatrics|February 4, 2014
Pediatric oncology drug shortages: a multifaceted problemDianne Murphy, Gregory Reaman, Capt Valerie Jensen
Current Opinion in Pediatrics|December 19, 2024
The childhood cancer data initiative: enabling data sharing to drive research advances and transform pediatric cancer diagnosis and treatmentSubhashini Jagu, Jaime M Guidry Auvil, Gregory Reaman
Regulatory Toxicology and Pharmacology : RTP|March 9, 2016
An FDA oncology view of juvenile animal studies in support of initial pediatric trials for anticancer drugsJohn K Leighton, Haleh Saber, Gregory Reaman, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 25, 2020
Crossing Oceans: Preclinical Collaboration to Improve Pediatric Drug DevelopmentGregory Reaman, Louis Stancato, Gilles Vassal, et al.
Pediatric Blood & Cancer|January 22, 2013
The impact of the written request process on drug development in childhood cancerKristen M Snyder, Gregory Reaman, Debbie Avant, et al.
Pediatric Blood & Cancer|May 31, 2019
Cancer drugs approved for use in children: Impact of legislative initiatives and future opportunitiesAmy Barone, Denise Casey, Amy E McKee, et al.
Pharmaceutical Statistics|June 16, 2020
A Bayesian approach in design and analysis of pediatric cancer clinical trialsJingjing Ye, Gregory Reaman, R Angelo De Claro, et al.
Journal of Biopharmaceutical Statistics|January 5, 2023
Utility of propensity score-based Bayesian borrowing of external adult data in pediatric trials: A pragmatic evaluation through a case study in acute lymphoblastic leukemia (ALL)Antara Majumdar, Rebecca Rothwell, Gregory Reaman, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Journal of Biopharmaceutical Statistics|February 7, 2023
Clinical trial considerations for pediatric cancer drug developmentFreda Cooner, Jingjing Ye, Gregory Reaman
Pediatric Blood & Cancer|February 27, 2013
Patient-perceived facilitators in the transition of care for young adult survivors of childhood cancerKarim Thomas Sadak, Amanda Dinofia, Gregory Reaman
Pediatrics|February 4, 2014
Pediatric oncology drug shortages: a multifaceted problemDianne Murphy, Gregory Reaman, Capt Valerie Jensen
Current Opinion in Pediatrics|December 19, 2024
The childhood cancer data initiative: enabling data sharing to drive research advances and transform pediatric cancer diagnosis and treatmentSubhashini Jagu, Jaime M Guidry Auvil, Gregory Reaman
Regulatory Toxicology and Pharmacology : RTP|March 9, 2016
An FDA oncology view of juvenile animal studies in support of initial pediatric trials for anticancer drugsJohn K Leighton, Haleh Saber, Gregory Reaman, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 25, 2020
Crossing Oceans: Preclinical Collaboration to Improve Pediatric Drug DevelopmentGregory Reaman, Louis Stancato, Gilles Vassal, et al.
Pediatric Blood & Cancer|January 22, 2013
The impact of the written request process on drug development in childhood cancerKristen M Snyder, Gregory Reaman, Debbie Avant, et al.
Pediatric Blood & Cancer|May 31, 2019
Cancer drugs approved for use in children: Impact of legislative initiatives and future opportunitiesAmy Barone, Denise Casey, Amy E McKee, et al.
Pharmaceutical Statistics|June 16, 2020
A Bayesian approach in design and analysis of pediatric cancer clinical trialsJingjing Ye, Gregory Reaman, R Angelo De Claro, et al.
Journal of Biopharmaceutical Statistics|January 5, 2023
Utility of propensity score-based Bayesian borrowing of external adult data in pediatric trials: A pragmatic evaluation through a case study in acute lymphoblastic leukemia (ALL)Antara Majumdar, Rebecca Rothwell, Gregory Reaman, et al.
Pageof 9